Technetium Tc 99m Sestamibi
"Technetium Tc 99m Sestamibi" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack.
| Descriptor ID |
D017256
|
| MeSH Number(s) |
D02.626.872 D02.691.825.937
|
| Concept/Terms |
Technetium Tc 99m Sestamibi- Technetium Tc 99m Sestamibi
- Tc-99m-Methoxy-2-isobutylisonitrile
- Tc 99m Methoxy 2 isobutylisonitrile
- Technetium-99m-Hexamibi
- Technetium 99m Hexamibi
- Tc MIBI
- 99mTc-Hexamibi
- 99mTc Hexamibi
- 99mTc-Sestamibi
- 99mTc Sestamibi
- Technetium Tc 99m 2-Methoxy-2-methylpropylisonitrile
- Technetium Tc 99m 2 Methoxy 2 methylpropylisonitrile
- Technetium-99m-Sestamibi
- Technetium 99m Sestamibi
|
Below are MeSH descriptors whose meaning is more general than "Technetium Tc 99m Sestamibi".
Below are MeSH descriptors whose meaning is more specific than "Technetium Tc 99m Sestamibi".
This graph shows the total number of publications written about "Technetium Tc 99m Sestamibi" by people in this website by year, and whether "Technetium Tc 99m Sestamibi" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 1 | 4 |
| 1996 | 2 | 0 | 2 |
| 1997 | 4 | 3 | 7 |
| 1998 | 1 | 2 | 3 |
| 1999 | 1 | 2 | 3 |
| 2000 | 2 | 2 | 4 |
| 2002 | 0 | 3 | 3 |
| 2003 | 0 | 2 | 2 |
| 2004 | 2 | 0 | 2 |
| 2005 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Technetium Tc 99m Sestamibi" by people in Profiles.
-
Gazivoda V, Prioli KM, Li AC, Pizzi L, Laird AM, Beninato T. Which Localizing Strategy is the Most Cost-Effective in Reoperative Primary Hyperparathyroidism? J Surg Res. 2024 Apr; 296:547-555.
-
Fendrich V, Zahn A. [Localization diagnostics and operative strategy for the first intervention in sporadic primary hyperparathyroidism]. Chirurgie (Heidelb). 2023 Jul; 94(7):573-579.
-
Iwen KA, Ku?mann J, Fendrich V, Lindner K, Zahn A. Accuracy of Parathyroid Adenoma Localization by Preoperative Ultrasound and Sestamibi in 1089 Patients with Primary Hyperparathyroidism. World J Surg. 2022 09; 46(9):2197-2205.
-
Nahass M, Kempf J. Severe myocardial stunning after myocardial perfusion on gated SPECT exercise stress test. J Nucl Cardiol. 2023 04; 30(2):839-843.
-
Camenzuli C, DiMarco AN, Isaacs KE, Grant Y, Jackson J, Alsafi A, Harvey C, Barwick TD, Tolley N, Palazzo FF. The changing face of reoperative parathyroidectomy: a single-centre comparison of 147 parathyroid reoperations. Ann R Coll Surg Engl. 2021 Jan; 103(1):29-34.
-
Kedarisetty S, Fundakowski C, Ramakrishnan K, Dadparvar S. Clinical Value of Tc99m-MIBI SPECT/CT Versus 4D-CT or US in Management of Patients With Hyperparathyroidism. Ear Nose Throat J. 2019 Mar; 98(3):149-157.
-
DE Simone B, Del Rio P, Catena F, Fallani G, Bendinelli C, Napoli JA, Zaccaroni A, Sianesi M. Preoperative localization of parathyroid adenoma in video-assisted era: is cervical ultrasound or 99mTc Sesta MIBI scintigraphy better? Minerva Chir. 2017 Oct; 72(5):375-382.
-
Studenski MT. Effective dose to patients and staff when using a mobile PET/SPECT system. J Appl Clin Med Phys. 2013 May 06; 14(3):4250.
-
Robinson B, Goudie B, Remmert J, Gidding SS. Usefulness of myocardial perfusion imaging with exercise testing in children. Pediatr Cardiol. 2012 Oct; 33(7):1061-8.
-
Adler JT, Chen H, Schaefer S, Sippel RS. What is the added benefit of cervical ultrasound to ??mTc-sestamibi scanning in primary hyperparathyroidism? Ann Surg Oncol. 2011 Oct; 18(10):2907-11.